Medical devices, healthcare technology and the business of care
510(k) clearance · K262437

Single-use Digital Flexible Ureteroscope (GY-UR6.3); Single-use Digital Flexible Ureteroscope (GY-UR6.3A)

Zhejiang Geyi Medical Instrument Co., Ltd. · Decision date Oct 29, 2026

MEDTECHLEDGER EXPLANATIONK262437

What did the FDA decide?

FDA recorded a substantial equivalence (SESE) decision on 2026-10-29 for premarket notification K262437, submitted by Zhejiang Geyi Medical Instrument Co., Ltd. of Jiande City, China, with Cathy Tan listed as applicant contact. The notification covers two single-use digital flexible ureteroscopes, GY-UR6.3 and GY-UR6.3A, under product code FGB in the Gastroenterology, Urology specialty. The record shows a receipt date of 07/16/2026.

SESE indicates the submission was cleared as substantially equivalent to a predicate device; it is not a PMA approval. The source does not identify the predicate device, the specific differences between the two model numbers, or any conditions of clearance, so the basis for the equivalence finding and any labeling constraints remain unknown from this record. No clinical or performance conclusions are drawn here.

Researchers comparing this clearance with earlier flexible ureteroscope submissions should treat the two model designations as a single notification rather than separate decisions, and should consult the full FDA document for predicate and labeling details.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Gastroenterology, Urology
Decision date
Oct 29, 2026
FDA decision documents: 510(k) Premarket Notification - FDA

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262437
Regulatory pathway
510(k) premarket notification
Product code
FGB
Decision code
SESE
Decision date
Oct 29, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Ureteroscope And Accessories, Flexible/Rigid.

Product code
FGB
FDA device class
2

FDA decision timeline

  1. K262437 received

    Application receipt date recorded by FDA.

  2. K262437 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code FGB

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Zhejiang Geyi Medical Instrument Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Jiande City

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records